Literature DB >> 20936980

Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.

Timothy J Henrich1, Jonathan Z Li, Donna Felsenstein, Camille N Kotton, Robert M Plenge, Florencia Pereyra, Francisco M Marty, Nina H Lin, Paul Grazioso, Danielle M Crochiere, Daniel Eggers, Daniel R Kuritzkes, Athe M N Tsibris.   

Abstract

We investigated the prevalence of xenotropic murine leukemia virus-related virus (XMRV) among 293 participants seen at academic hospitals in Boston, Massachusetts. Participants were recruited from the following 5 groups of patients: chronic fatigue syndrome (n = 32), human immunodeficiency virus infection (n = 43), rheumatoid arthritis (n = 97), hematopoietic stem-cell or solid organ transplant (n = 26), or a general cohort of patients presenting for medical care (n = 95). XMRV DNA was not detected in any participant samples. We found no association between XMRV and patients with chronic fatigue syndrome or chronic immunomodulatory conditions.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20936980      PMCID： PMC2957553          DOI： 10.1086/657168

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  15 in total

1.  Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection.

Authors:  J W Gow; K Simpson; P O Behan; A Chaudhuri; I C McKay; W M Behan
Journal:  Clin Infect Dis       Date:  2001-11-06       Impact factor: 9.079

2.  Instrumenting the health care enterprise for discovery research in the genomic era.

Authors:  Shawn Murphy; Susanne Churchill; Lynn Bry; Henry Chueh; Scott Weiss; Ross Lazarus; Qing Zeng; Anil Dubey; Vivian Gainer; Michael Mendis; John Glaser; Isaac Kohane
Journal:  Genome Res       Date:  2009-07-14       Impact factor: 9.043

3.  Truncated gag products encoded by Gv-1-responsive endogenous retrovirus loci.

Authors:  P F Policastro; M Fredholm; M C Wilson
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

Review 4.  Xenotropic type C viruses.

Authors:  J A Levy
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

5.  Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer.

Authors:  Nicole Fischer; Olaf Hellwinkel; Claudia Schulz; Felix K H Chun; Hartwig Huland; Martin Aepfelbacher; Thorsten Schlomm
Journal:  J Clin Virol       Date:  2008-09-27       Impact factor: 3.168

6.  Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

Authors:  Florencia Pereyra; Marylyn M Addo; Daniel E Kaufmann; Yang Liu; Toshiyuki Miura; Almas Rathod; Brett Baker; Alicja Trocha; Rachel Rosenberg; Elizabeth Mackey; Peggy Ueda; Zhigang Lu; Daniel Cohen; Terri Wrin; Christos J Petropoulos; Eric S Rosenberg; Bruce D Walker
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

Review 7.  Elite control of HIV Infection: implications for vaccines and treatment.

Authors:  Bruce D Walker
Journal:  Top HIV Med       Date:  2007 Aug-Sep

8.  Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome.

Authors:  R J Suhadolnik; N L Reichenbach; P Hitzges; R W Sobol; D L Peterson; B Henry; D V Ablashi; W E Müller; H C Schröder; W A Carter
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

9.  XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors.

Authors:  Robert Schlaberg; Daniel J Choe; Kristy R Brown; Harshwardhan M Thaker; Ila R Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

10.  Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Authors:  Anatoly Urisman; Ross J Molinaro; Nicole Fischer; Sarah J Plummer; Graham Casey; Eric A Klein; Krishnamurthy Malathi; Cristina Magi-Galluzzi; Raymond R Tubbs; Don Ganem; Robert H Silverman; Joseph L DeRisi
Journal:  PLoS Pathog       Date:  2006-03-31       Impact factor: 6.823
View more
  38 in total

1.  NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.

Authors:  Shuhei Sakakibara; Kaori Sakakibara; Giovanna Tosato
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 2.  Is XMRV a causal virus for prostate cancer?

Authors:  Zhen-Zhen Zhang; Bao-Feng Guo; Zhuang Feng; Ling Zhang; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

Review 3.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

4.  Development of sensitive single-round pol or env RT-PCR assays to screen for XMRV in multiple sample types.

Authors:  Ning Tang; Andrea Frank; Gregor Leckie; John Hackett; Graham Simmons; Michael Busch; Klara Abravaya
Journal:  J Virol Methods       Date:  2011-10-25       Impact factor: 2.014

5.  The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans.

Authors:  Graham Simmons; Simone A Glynn; Jerry A Holmberg; John M Coffin; Indira K Hewlett; Shyh-Ching Lo; Judy A Mikovits; William M Switzer; Jeffrey M Linnen; Michael P Busch
Journal:  Transfusion       Date:  2011-03-01       Impact factor: 3.157

6.  Xenotropic murine leukemia virus-related virus in monozygotic twins discordant for chronic fatigue syndrome.

Authors:  Keith R Jerome; Kurt Diem; Meei-Li Huang; Stacy Selke; Lawrence Corey; Dedra Buchwald
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07-26       Impact factor: 2.803

7.  Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques.

Authors:  Gregory Q Del Prete; Mary F Kearney; Jon Spindler; Ann Wiegand; Elena Chertova; James D Roser; Jacob D Estes; Xing Pei Hao; Charles M Trubey; Abigail Lara; Kyeongeun Lee; Chawaree Chaipan; Julian W Bess; Kunio Nagashima; Brandon F Keele; Rhonda Macallister; Jeremy Smedley; Vinay K Pathak; Vineet N Kewalramani; John M Coffin; Jeffrey D Lifson
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

8.  Xenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosus.

Authors:  Eva Balada; Jesús Castro-Marrero; Lledó Felip; Miquel Vilardell-Tarrés; Josep Ordi-Ros
Journal:  J Clin Immunol       Date:  2011-04-21       Impact factor: 8.317

9.  Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome.

Authors:  Clifford H Shin; Lucinda Bateman; Robert Schlaberg; Ashley M Bunker; Christopher J Leonard; Ronald W Hughen; Alan R Light; Kathleen C Light; Ila R Singh
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 10.  Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.

Authors:  Zhi-Ming Zheng
Journal:  Int J Biol Sci       Date:  2010-12-01       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.